Index by Author

June 2026; 32 (6)
  1. A
  2. B
  3. C
  4. D
  5. E
  6. F
  7. G
  8. H
  9. I
  10. J
  11. K
  12. L
  13. M
  14. N
  15. O
  16. P
  17. Q
  18. R
  19. S
  20. T
  21. U
  22. V
  23. W
  24. X
  25. Y
  26. Z

A

  1. Akinniyi, Oluwasegun T.

    • Degradation factor 1, Def1, regulates mRNA translation and decay through Ccr4–Not-dependent ubiquitylation of the ribosome RNA June 2026 32: 930-944; Published in Advance March 10, 2026, doi:10.1261/rna.080884.125
      OPEN ACCESS ARTICLE

  2. Albert, Istvan

    • Degradation factor 1, Def1, regulates mRNA translation and decay through Ccr4–Not-dependent ubiquitylation of the ribosome RNA June 2026 32: 930-944; Published in Advance March 10, 2026, doi:10.1261/rna.080884.125
      OPEN ACCESS ARTICLE

  3. Alspach, Clay

    • mRNA COVID-19 vaccines: science versus misinformation RNA June 2026 32: 759-771; Published in Advance March 18, 2026, doi:10.1261/rna.080944.126
      OPEN ACCESS ARTICLE

  4. Alzate, Alejandra Romero

    • Canonical microRNA loss drives tumor development, implicating therapeutic efficacy of enoxacin in angiosarcoma RNA June 2026 32: 812-826; Published in Advance February 26, 2026, doi:10.1261/rna.080706.125
      OPEN ACCESS ARTICLE

  5. Amoruso, Damiano

  6. Arribere, Joshua A.

B

  1. Baymiller, Max

    • Tuning tRNA synthetase inhibition reveals parabolic induction of stress granules limited in size and RNA content RNA June 2026 32: 870-884; Published in Advance February 8, 2026, doi:10.1261/rna.080883.125
      OPEN ACCESS ARTICLE

  2. Benton, Annaleigh

    • Canonical microRNA loss drives tumor development, implicating therapeutic efficacy of enoxacin in angiosarcoma RNA June 2026 32: 812-826; Published in Advance February 26, 2026, doi:10.1261/rna.080706.125
      OPEN ACCESS ARTICLE

  3. Bronzini, Juliana M.

    • Canonical microRNA loss drives tumor development, implicating therapeutic efficacy of enoxacin in angiosarcoma RNA June 2026 32: 812-826; Published in Advance February 26, 2026, doi:10.1261/rna.080706.125
      OPEN ACCESS ARTICLE

  4. Budka, William

    • Canonical microRNA loss drives tumor development, implicating therapeutic efficacy of enoxacin in angiosarcoma RNA June 2026 32: 812-826; Published in Advance February 26, 2026, doi:10.1261/rna.080706.125
      OPEN ACCESS ARTICLE

  5. Bystry, Vojtech

C

  1. Cheeseman, Iain M.

    • Regulation of mRNA decay and translation during the mammalian cell cycle RNA June 2026 32: 775-788; Published in Advance February 5, 2026, doi:10.1261/rna.080910.125
      OPEN ACCESS ARTICLE

  2. Chernyavskaya, Ekaterina

  3. Clostres, Emmanuel

    • Bioinformatic and experimental analyses revealed pathogen-derived pathoPEP candidates predicted to control plant miRNA expression and infection RNA June 2026 32: 915-929; Published in Advance March 19, 2026, doi:10.1261/rna.080819.125

  4. Coller, Jeff

    • mRNA COVID-19 vaccines: science versus misinformation RNA June 2026 32: 759-771; Published in Advance March 18, 2026, doi:10.1261/rna.080944.126
      OPEN ACCESS ARTICLE

D

  1. Daburon, Virginie

    • Bioinformatic and experimental analyses revealed pathogen-derived pathoPEP candidates predicted to control plant miRNA expression and infection RNA June 2026 32: 915-929; Published in Advance March 19, 2026, doi:10.1261/rna.080819.125

  2. Daval, Stéphanie

    • Bioinformatic and experimental analyses revealed pathogen-derived pathoPEP candidates predicted to control plant miRNA expression and infection RNA June 2026 32: 915-929; Published in Advance March 19, 2026, doi:10.1261/rna.080819.125

  3. Dodd, Benjamin

    • Tuning tRNA synthetase inhibition reveals parabolic induction of stress granules limited in size and RNA content RNA June 2026 32: 870-884; Published in Advance February 8, 2026, doi:10.1261/rna.080883.125
      OPEN ACCESS ARTICLE

  4. Dontsova, Olga A.

  5. Duncan, Roberta

    • mRNA COVID-19 vaccines: science versus misinformation RNA June 2026 32: 759-771; Published in Advance March 18, 2026, doi:10.1261/rna.080944.126
      OPEN ACCESS ARTICLE

  6. Dunn, Christian R.

E

  1. El-Amrani, Abdelhak

    • Bioinformatic and experimental analyses revealed pathogen-derived pathoPEP candidates predicted to control plant miRNA expression and infection RNA June 2026 32: 915-929; Published in Advance March 19, 2026, doi:10.1261/rna.080819.125

  2. Elhajjajy, Shaimae I.

    • A novel NLP-based method and algorithm to discover RNA-binding protein (RBP) motifs, contexts, binding preferences, and interactions RNA June 2026 32: 885-914; Published in Advance February 19, 2026, doi:10.1261/rna.080892.125
      OPEN ACCESS ARTICLE

G

  1. Gartenhaus, Lauren

    • Canonical microRNA loss drives tumor development, implicating therapeutic efficacy of enoxacin in angiosarcoma RNA June 2026 32: 812-826; Published in Advance February 26, 2026, doi:10.1261/rna.080706.125
      OPEN ACCESS ARTICLE

  2. Gazengel, Kévin

    • Bioinformatic and experimental analyses revealed pathogen-derived pathoPEP candidates predicted to control plant miRNA expression and infection RNA June 2026 32: 915-929; Published in Advance March 19, 2026, doi:10.1261/rna.080819.125

  3. Geall, Andrew

    • mRNA COVID-19 vaccines: science versus misinformation RNA June 2026 32: 759-771; Published in Advance March 18, 2026, doi:10.1261/rna.080944.126
      OPEN ACCESS ARTICLE

  4. Gebauer, Fátima

    • mRNA COVID-19 vaccines: science versus misinformation RNA June 2026 32: 759-771; Published in Advance March 18, 2026, doi:10.1261/rna.080944.126
      OPEN ACCESS ARTICLE

  5. Gnazzo, Victoria

  6. Guydosh, Nicholas R.

    • Stalled translation on transcripts cleaved by RNase L activates signaling important for innate immunity RNA June 2026 32: 945-961; Published in Advance February 26, 2026, doi:10.1261/rna.080699.125
      OPEN ACCESS ARTICLE

H

  1. Haag, Benjamin L.

  2. Hackbart, Matthew

  3. Hajji, Khadija

  4. Hanna, Jason A.

    • Canonical microRNA loss drives tumor development, implicating therapeutic efficacy of enoxacin in angiosarcoma RNA June 2026 32: 812-826; Published in Advance February 26, 2026, doi:10.1261/rna.080706.125
      OPEN ACCESS ARTICLE

  5. Hartzler, Samuel

    • Canonical microRNA loss drives tumor development, implicating therapeutic efficacy of enoxacin in angiosarcoma RNA June 2026 32: 812-826; Published in Advance February 26, 2026, doi:10.1261/rna.080706.125
      OPEN ACCESS ARTICLE

  6. Helton, Noah S.

    • Tuning tRNA synthetase inhibition reveals parabolic induction of stress granules limited in size and RNA content RNA June 2026 32: 870-884; Published in Advance February 8, 2026, doi:10.1261/rna.080883.125
      OPEN ACCESS ARTICLE

J

  1. Jackman, Jane E.

    • A comparison of Dictyostelium discoideum 3′-5′ RNA polymerases reveals a conserved tRNAHis guanylyltransferase residue that plays a dual role in catalysis RNA June 2026 32: 843-857; Published in Advance February 4, 2026, doi:10.1261/rna.080815.125

  2. Janson, Nimod D.

    • Canonical microRNA loss drives tumor development, implicating therapeutic efficacy of enoxacin in angiosarcoma RNA June 2026 32: 812-826; Published in Advance February 26, 2026, doi:10.1261/rna.080706.125
      OPEN ACCESS ARTICLE

  3. Jayasundara, Shyaman

    • Canonical microRNA loss drives tumor development, implicating therapeutic efficacy of enoxacin in angiosarcoma RNA June 2026 32: 812-826; Published in Advance February 26, 2026, doi:10.1261/rna.080706.125
      OPEN ACCESS ARTICLE

  4. Johnecheck, Grace N.

    • A comparison of Dictyostelium discoideum 3′-5′ RNA polymerases reveals a conserved tRNAHis guanylyltransferase residue that plays a dual role in catalysis RNA June 2026 32: 843-857; Published in Advance February 4, 2026, doi:10.1261/rna.080815.125

  5. Jones, Grant D.

    • Stalled translation on transcripts cleaved by RNase L activates signaling important for innate immunity RNA June 2026 32: 945-961; Published in Advance February 26, 2026, doi:10.1261/rna.080699.125
      OPEN ACCESS ARTICLE

K

  1. Karasik, Agnes

    • Stalled translation on transcripts cleaved by RNase L activates signaling important for innate immunity RNA June 2026 32: 945-961; Published in Advance February 26, 2026, doi:10.1261/rna.080699.125
      OPEN ACCESS ARTICLE

  2. Karousis, Evangelos D.

    • NMD takes two PIN domains to tango RNA June 2026 32: 772-774; Published in Advance March 11, 2026, doi:10.1261/rna.081027.126
      OPEN ACCESS ARTICLE

  3. Kazemian, Majid

    • Canonical microRNA loss drives tumor development, implicating therapeutic efficacy of enoxacin in angiosarcoma RNA June 2026 32: 812-826; Published in Advance February 26, 2026, doi:10.1261/rna.080706.125
      OPEN ACCESS ARTICLE

  4. Keegan, Liam P.

  5. Khalizeva, Ekaterina

    • Regulation of mRNA decay and translation during the mammalian cell cycle RNA June 2026 32: 775-788; Published in Advance February 5, 2026, doi:10.1261/rna.080910.125
      OPEN ACCESS ARTICLE

  6. Khan, Anzer

  7. Kihm, Korey J.

    • A comparison of Dictyostelium discoideum 3′-5′ RNA polymerases reveals a conserved tRNAHis guanylyltransferase residue that plays a dual role in catalysis RNA June 2026 32: 843-857; Published in Advance February 4, 2026, doi:10.1261/rna.080815.125

  8. Kulkarni, Shardul

    • Degradation factor 1, Def1, regulates mRNA translation and decay through Ccr4–Not-dependent ubiquitylation of the ribosome RNA June 2026 32: 930-944; Published in Advance March 10, 2026, doi:10.1261/rna.080884.125
      OPEN ACCESS ARTICLE

L

  1. Lanman, Nadia A.

    • Canonical microRNA loss drives tumor development, implicating therapeutic efficacy of enoxacin in angiosarcoma RNA June 2026 32: 812-826; Published in Advance February 26, 2026, doi:10.1261/rna.080706.125
      OPEN ACCESS ARTICLE

  2. Liu, Bozhi

    • Canonical microRNA loss drives tumor development, implicating therapeutic efficacy of enoxacin in angiosarcoma RNA June 2026 32: 812-826; Published in Advance February 26, 2026, doi:10.1261/rna.080706.125
      OPEN ACCESS ARTICLE

  3. López, Carolina B.

  4. Ly, Jimmy

    • Regulation of mRNA decay and translation during the mammalian cell cycle RNA June 2026 32: 775-788; Published in Advance February 5, 2026, doi:10.1261/rna.080910.125
      OPEN ACCESS ARTICLE

M

  1. Medaglia-Mata, Alejandro

  2. Modena, Matthew S.

  3. Monard, Cécile

    • Bioinformatic and experimental analyses revealed pathogen-derived pathoPEP candidates predicted to control plant miRNA expression and infection RNA June 2026 32: 915-929; Published in Advance March 19, 2026, doi:10.1261/rna.080819.125

  4. Moon, Stephanie L.

    • Tuning tRNA synthetase inhibition reveals parabolic induction of stress granules limited in size and RNA content RNA June 2026 32: 870-884; Published in Advance February 8, 2026, doi:10.1261/rna.080883.125
      OPEN ACCESS ARTICLE

  5. Moore, Melissa J.

    • mRNA COVID-19 vaccines: science versus misinformation RNA June 2026 32: 759-771; Published in Advance March 18, 2026, doi:10.1261/rna.080944.126
      OPEN ACCESS ARTICLE

  6. Mühlemann, Oliver

    • NMD takes two PIN domains to tango RNA June 2026 32: 772-774; Published in Advance March 11, 2026, doi:10.1261/rna.081027.126
      OPEN ACCESS ARTICLE

  7. Murphy, Ant

    • Canonical microRNA loss drives tumor development, implicating therapeutic efficacy of enoxacin in angiosarcoma RNA June 2026 32: 812-826; Published in Advance February 26, 2026, doi:10.1261/rna.080706.125
      OPEN ACCESS ARTICLE

N

  1. Nováková, Barbora

O

  1. O'Connell, Mary A.

P

  1. Penno, Christophe

    • Bioinformatic and experimental analyses revealed pathogen-derived pathoPEP candidates predicted to control plant miRNA expression and infection RNA June 2026 32: 915-929; Published in Advance March 19, 2026, doi:10.1261/rna.080819.125

  2. Pervouchine, Dmitri D.

  3. Picardi, Ernesto

  4. Primig, Julian

    • Genetic and genomic approaches to explore roles for the conserved 3′-5′ exoribonuclease EXOSC10 in normal and malignant cells RNA June 2026 32: 789-801; Published in Advance February 25, 2026, doi:10.1261/rna.080981.126
      OPEN ACCESS ARTICLE

  5. Primig, Michael

    • Genetic and genomic approaches to explore roles for the conserved 3′-5′ exoribonuclease EXOSC10 in normal and malignant cells RNA June 2026 32: 789-801; Published in Advance February 25, 2026, doi:10.1261/rna.080981.126
      OPEN ACCESS ARTICLE

R

  1. Reese, Joseph C.

    • Degradation factor 1, Def1, regulates mRNA translation and decay through Ccr4–Not-dependent ubiquitylation of the ribosome RNA June 2026 32: 930-944; Published in Advance March 10, 2026, doi:10.1261/rna.080884.125
      OPEN ACCESS ARTICLE

  2. Ryder, Sean

    • mRNA COVID-19 vaccines: science versus misinformation RNA June 2026 32: 759-771; Published in Advance March 18, 2026, doi:10.1261/rna.080944.126
      OPEN ACCESS ARTICLE

S

  1. Sain, Radhika

    • Genetic and genomic approaches to explore roles for the conserved 3′-5′ exoribonuclease EXOSC10 in normal and malignant cells RNA June 2026 32: 789-801; Published in Advance February 25, 2026, doi:10.1261/rna.080981.126
      OPEN ACCESS ARTICLE

  2. Sambrani, Nagraj

  3. Sebastian, Aswathy

    • Degradation factor 1, Def1, regulates mRNA translation and decay through Ccr4–Not-dependent ubiquitylation of the ribosome RNA June 2026 32: 930-944; Published in Advance March 10, 2026, doi:10.1261/rna.080884.125
      OPEN ACCESS ARTICLE

  4. Silvestris, Domenico Alessandro

  5. Skvortsov, Dmitry A.

  6. Spirin, Sergei A.

T

  1. Tao, Yi Fei

    • Regulation of mRNA decay and translation during the mammalian cell cycle RNA June 2026 32: 775-788; Published in Advance February 5, 2026, doi:10.1261/rna.080910.125
      OPEN ACCESS ARTICLE

U

  1. Utturkar, Sagar

    • Canonical microRNA loss drives tumor development, implicating therapeutic efficacy of enoxacin in angiosarcoma RNA June 2026 32: 812-826; Published in Advance February 26, 2026, doi:10.1261/rna.080706.125
      OPEN ACCESS ARTICLE

V

  1. Viscardi, Marcus J.

  2. Vorobeva, Margarita

W

  1. Wang, Patrick

  2. Weng, Zhiping

    • A novel NLP-based method and algorithm to discover RNA-binding protein (RBP) motifs, contexts, binding preferences, and interactions RNA June 2026 32: 885-914; Published in Advance February 19, 2026, doi:10.1261/rna.080892.125
      OPEN ACCESS ARTICLE

  3. Wohlenberg, Chloe M.

Y

  1. Yang, Deying

  2. Yates, Madison E.

    • Canonical microRNA loss drives tumor development, implicating therapeutic efficacy of enoxacin in angiosarcoma RNA June 2026 32: 812-826; Published in Advance February 26, 2026, doi:10.1261/rna.080706.125
      OPEN ACCESS ARTICLE

Current Issue

  1. July 2026, 32 (7)
  1. Current Issue
  1. Alert me to new issues of RNA